A nurse understands that a central nervous system (CNS) stimulant would be indicated for a patient with which of the following health alterations?

A. Ask a colleague what the order says:

This option involves seeking assistance from a colleague to interpret the illegible handwriting. While collaboration among healthcare professionals is important, relying on a colleague to interpret unclear handwriting may introduce the risk of miscommunication or misinterpretation.

B. Contact the prescriber to clarify the order:

This is the recommended and safest option. Contacting the prescriber directly to seek clarification ensures accurate information and reduces the risk of misinterpretation or errors related to illegible handwriting.

C. Wait until the prescriber makes rounds again to clarify the order:

This option involves delaying clarification until the prescriber is available during rounds. Waiting may not be ideal if the patient requires prompt intervention or if there is an urgency in administering the medication. Timely communication is crucial for patient safety.

D. Ask the patient what medications he takes at home:

This option is unrelated to the issue of illegible handwriting on the prescription. While obtaining a patient's medication history is important for comprehensive care, it does not address the immediate need to clarify the unclear order.

A. Combination therapy has the best outcomes when omeprazole, propranolol, bismuth salicylate are used.

Propranolol is not an antibiotic and is not part of the standard combination therapy for H. pylori. Bismuth subsalicylate may be used in some regimens, but the standard involves a proton pump inhibitor, clarithromycin, and amoxicillin or metronidazole.

B. Combination therapy has the best outcomes when omeprazole, clarithromycin, and amoxicillin are used.

This is the correct choice. The standard combination therapy for H. pylori infection includes a proton pump inhibitor (such as omeprazole), clarithromycin, and amoxicillin or metronidazole.

C. The use of sucralfate along with antibiotics is the best combination therapy for peptic ulcer disease.

Sucralfate is not typically part of the standard antibiotic combination therapy for H. pylori. It is a cytoprotective agent that may be used to treat ulcers but is not a primary component in eradicating H. pylori.

D. Various antibiotics are used to eradicate the bacteria that are responsible for the development of peptic ulcer disease.

While this statement is true, it does not specify the standard combination therapy. The most common antibiotics used in combination therapy for H. pylori include clarithromycin and amoxicillin or metronidazole, along with a proton pump inhibitor.